Category: Head and Neck Cancer Group

Biostatistics
Head and Neck Cancer Group / Press release

First european biomarker driven umbrella trial in recurrent / metastatic squamous cell carcinoma of the head & neck

26 Jun
Lisa-Licitra
Head and Neck Cancer Group / News

Debiopharm and EORTC announce a collaboration to investigate Triptorelin for treatment of Salivary Gland Cancers

13 Jan
water-web
Head and Neck Cancer Group / News

EORTC trial evaluates androgen deprivation therapy for patients with recurrent / metastatic androgen receptor expressing salivary gland cancer

10 Feb
profile
Head and Neck Cancer Group / News / Uncategorized

EORTC initiates randomized phase III study with Azanta’s Nimoral®

18 Aug
profile
Head and Neck Cancer Group / News / Uncategorized

EORTC and DAHANCA launch trial for patients with locally advanced squamous cell carcinoma of the head and neck

4 Jun
thyroid
Head and Neck Cancer Group / News / Uncategorized

EORTC trial opens for patients with differentiated or medullary thyroid cancer progressing after first line therapy

20 May
thyroid
Head and Neck Cancer Group / News / Quality of Life Group / Uncategorized

EORTC head & neck cancer trial shows assessing HRQOL is valuable to both patients and their doctors

20 Nov
labo
Head and Neck Cancer Group / News / Uncategorized

Addressing treatment resistance in patients with squamous cell carcinoma of head and neck with Pr. Machiels and Blanpain

13 Sep
Genito-Urinary Cancers Group / Head and Neck Cancer Group / Lung Cancer Group / Melanoma Group / News / Radiation Oncology Group / Soft Tissue and Bone Sarcoma Group / Uncategorized

Abstracts accepted for the 2011 ASCO Annual Meeting

28 Apr
Brain Tumor Group / Breast Cancer Group / Gastrointestinal Tract Cancer Group / Genito-Urinary Cancers Group / Head and Neck Cancer Group / Lymphoma Group / News / Radiation Oncology Group / Uncategorized

EORTC studies opened since 12 March 2010

27 May
1 2 3 … 41